Enhancement of parathyroid hormone-stimulated bone resorption by poly-l-lysine

L. G. Raisz, P. J. Bergmann, Jesus Dominguez, M. A. Price

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Poly-L-lysine (PL II; mol wt, 1000-4000) was added to fetal rat bones cultured in a chemically defined medium (BGJ) containing bovine serum albumin in the presence and absence of parathyroid hormone (PTH). Bone resorption was measured by the release of previously incorporated 45Ca. The addition of PL II at concentrations of 3-100 μg/ml enhanced the stimulation of bone resorption by submaximal doses of PTH but had little effect on 45Ca release from control unstimulated cultures. Higher concentrations of PL II produced inhibition of 45Ca release. Dialysis of PL II did not alter enhancement or inhibition by PL II. PL II did not increase sensitivity to PTH in serum-supplemented cultures. Higher molecular weight PL II preparations were less effective. PL II did not enhance the resorptive response to 1,25-dihydroxyvitamin D, prostaglandin E2, osteoclast-activating factor, or bacterial endotoxin. The mechanism of the selective ability of PL II to enhance the response to low concentrations of PTH is unknown but may be due to the ability of this basic polypeptide to interfere with binding of PTH to sites other than the hormone receptor or to block degradation of PTH by bone.

Original languageEnglish (US)
Pages (from-to)152-155
Number of pages4
JournalEndocrinology
Volume105
Issue number1
StatePublished - 1979
Externally publishedYes

Fingerprint

Bone Resorption
Parathyroid Hormone
Lysine
1-myristoyl-2-(2-azido-4-nitrobenzoyl)phosphatidylcholine
Bone and Bones
Bovine Serum Albumin
Dinoprostone
Endotoxins
Dialysis
Molecular Weight
Hormones
Peptides
Serum

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Raisz, L. G., Bergmann, P. J., Dominguez, J., & Price, M. A. (1979). Enhancement of parathyroid hormone-stimulated bone resorption by poly-l-lysine. Endocrinology, 105(1), 152-155.

Enhancement of parathyroid hormone-stimulated bone resorption by poly-l-lysine. / Raisz, L. G.; Bergmann, P. J.; Dominguez, Jesus; Price, M. A.

In: Endocrinology, Vol. 105, No. 1, 1979, p. 152-155.

Research output: Contribution to journalArticle

Raisz, LG, Bergmann, PJ, Dominguez, J & Price, MA 1979, 'Enhancement of parathyroid hormone-stimulated bone resorption by poly-l-lysine', Endocrinology, vol. 105, no. 1, pp. 152-155.
Raisz, L. G. ; Bergmann, P. J. ; Dominguez, Jesus ; Price, M. A. / Enhancement of parathyroid hormone-stimulated bone resorption by poly-l-lysine. In: Endocrinology. 1979 ; Vol. 105, No. 1. pp. 152-155.
@article{e23ab082683c4ae6b3f34e3f55a345fd,
title = "Enhancement of parathyroid hormone-stimulated bone resorption by poly-l-lysine",
abstract = "Poly-L-lysine (PL II; mol wt, 1000-4000) was added to fetal rat bones cultured in a chemically defined medium (BGJ) containing bovine serum albumin in the presence and absence of parathyroid hormone (PTH). Bone resorption was measured by the release of previously incorporated 45Ca. The addition of PL II at concentrations of 3-100 μg/ml enhanced the stimulation of bone resorption by submaximal doses of PTH but had little effect on 45Ca release from control unstimulated cultures. Higher concentrations of PL II produced inhibition of 45Ca release. Dialysis of PL II did not alter enhancement or inhibition by PL II. PL II did not increase sensitivity to PTH in serum-supplemented cultures. Higher molecular weight PL II preparations were less effective. PL II did not enhance the resorptive response to 1,25-dihydroxyvitamin D, prostaglandin E2, osteoclast-activating factor, or bacterial endotoxin. The mechanism of the selective ability of PL II to enhance the response to low concentrations of PTH is unknown but may be due to the ability of this basic polypeptide to interfere with binding of PTH to sites other than the hormone receptor or to block degradation of PTH by bone.",
author = "Raisz, {L. G.} and Bergmann, {P. J.} and Jesus Dominguez and Price, {M. A.}",
year = "1979",
language = "English (US)",
volume = "105",
pages = "152--155",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "1",

}

TY - JOUR

T1 - Enhancement of parathyroid hormone-stimulated bone resorption by poly-l-lysine

AU - Raisz, L. G.

AU - Bergmann, P. J.

AU - Dominguez, Jesus

AU - Price, M. A.

PY - 1979

Y1 - 1979

N2 - Poly-L-lysine (PL II; mol wt, 1000-4000) was added to fetal rat bones cultured in a chemically defined medium (BGJ) containing bovine serum albumin in the presence and absence of parathyroid hormone (PTH). Bone resorption was measured by the release of previously incorporated 45Ca. The addition of PL II at concentrations of 3-100 μg/ml enhanced the stimulation of bone resorption by submaximal doses of PTH but had little effect on 45Ca release from control unstimulated cultures. Higher concentrations of PL II produced inhibition of 45Ca release. Dialysis of PL II did not alter enhancement or inhibition by PL II. PL II did not increase sensitivity to PTH in serum-supplemented cultures. Higher molecular weight PL II preparations were less effective. PL II did not enhance the resorptive response to 1,25-dihydroxyvitamin D, prostaglandin E2, osteoclast-activating factor, or bacterial endotoxin. The mechanism of the selective ability of PL II to enhance the response to low concentrations of PTH is unknown but may be due to the ability of this basic polypeptide to interfere with binding of PTH to sites other than the hormone receptor or to block degradation of PTH by bone.

AB - Poly-L-lysine (PL II; mol wt, 1000-4000) was added to fetal rat bones cultured in a chemically defined medium (BGJ) containing bovine serum albumin in the presence and absence of parathyroid hormone (PTH). Bone resorption was measured by the release of previously incorporated 45Ca. The addition of PL II at concentrations of 3-100 μg/ml enhanced the stimulation of bone resorption by submaximal doses of PTH but had little effect on 45Ca release from control unstimulated cultures. Higher concentrations of PL II produced inhibition of 45Ca release. Dialysis of PL II did not alter enhancement or inhibition by PL II. PL II did not increase sensitivity to PTH in serum-supplemented cultures. Higher molecular weight PL II preparations were less effective. PL II did not enhance the resorptive response to 1,25-dihydroxyvitamin D, prostaglandin E2, osteoclast-activating factor, or bacterial endotoxin. The mechanism of the selective ability of PL II to enhance the response to low concentrations of PTH is unknown but may be due to the ability of this basic polypeptide to interfere with binding of PTH to sites other than the hormone receptor or to block degradation of PTH by bone.

UR - http://www.scopus.com/inward/record.url?scp=0018770623&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018770623&partnerID=8YFLogxK

M3 - Article

C2 - 446405

AN - SCOPUS:0018770623

VL - 105

SP - 152

EP - 155

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 1

ER -